Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,457,359
-
Share change
-
-526,653
-
Total reported value
-
$86,598,000
-
Price per share
-
$4.68
-
Number of holders
-
49
-
Value change
-
-$4,226,710
-
Number of buys
-
22
-
Number of sells
-
39
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q2 2017
As of 30 Jun 2017,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,457,359 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, NEA Management Company, LLC, FMR LLC, JENNISON ASSOCIATES LLC, Hillhouse Capital Management, Ltd., PRICE T ROWE ASSOCIATES INC /MD/, Marshall Wace North America L.P., FIL Ltd, Rock Springs Capital Management LP, and HarbourVest Partners LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.